Cargando…

Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain

Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Timothy J. C., Yuan, Meng, Kuzelka, Kaylee, Padron, Gilberto C., Beal, Jacob R., Chen, Xin, Wang, Yiquan, Rivera-Cardona, Joel, Zhu, Xueyong, Stadtmueller, Beth M., Brooke, Christopher B., Wilson, Ian A., Wu, Nicholas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217500/
https://www.ncbi.nlm.nih.gov/pubmed/34155209
http://dx.doi.org/10.1038/s41467-021-24123-7
_version_ 1783710602737221632
author Tan, Timothy J. C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
author_facet Tan, Timothy J. C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
author_sort Tan, Timothy J. C.
collection PubMed
description Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2.
format Online
Article
Text
id pubmed-8217500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82175002021-07-09 Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain Tan, Timothy J. C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. Nat Commun Article Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2. Nature Publishing Group UK 2021-06-21 /pmc/articles/PMC8217500/ /pubmed/34155209 http://dx.doi.org/10.1038/s41467-021-24123-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tan, Timothy J. C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title_full Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title_fullStr Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title_full_unstemmed Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title_short Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
title_sort sequence signatures of two public antibody clonotypes that bind sars-cov-2 receptor binding domain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217500/
https://www.ncbi.nlm.nih.gov/pubmed/34155209
http://dx.doi.org/10.1038/s41467-021-24123-7
work_keys_str_mv AT tantimothyjc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT yuanmeng sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT kuzelkakaylee sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT padrongilbertoc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT bealjacobr sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT chenxin sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT wangyiquan sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT riveracardonajoel sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT zhuxueyong sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT stadtmuellerbethm sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT brookechristopherb sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT wilsoniana sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain
AT wunicholasc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain